In this episode of the Maximal Being podcast, Dr. Erica Barnell, founder of Geneoscopy, discusses leveraging stool RNA testing to revolutionize the diagnosis and treatment of inflammatory bowel diseases (IBD) like Crohn’s and ulcerative colitis. She shares her journey from microbiome research in Africa to developing an FDA-approved colorectal cancer screening test, and now focusing on personalized medicine for IBD. The conversation explores the potential of RNA biomarkers in improving patient outcomes, especially for young IBD patients.
Add A Comment